Egalet Corporation
  • Home
  • About Egalet
    • Company Overview
    • Management
    • Board of Directors
    • Compliance
  • Our Products
    • ARYMO® ER
    • OXAYDO®
    • SPRIX® Nasal Spray
  • R&D
    • Technology Overview
    • Pipeline
      • Chronic Pain
      • Prescription Drug Abuse
    • Manufacturing
    • Resources
  • Investors
    • Investor Home
    • Corporate Governance
    • News Releases
    • Financial Reporting
    • Stock Information
    • Events & Presentations
    • Investor Alerts
    • Press Kit
  • Contact Us
    • Contact Information
    • Careers
Follow @EgaletCorp
r_and_d_banner_small_bg@2x

Pipeline

Egalet Product Pipeline

Egalet has built a robust pipeline built around products developed using its Guardian™ Technology, and through business development. ARYMO ER is the first approved and marketed product to use Guardian Technology. The Company licensed and acquired OXAYDO and SPRIX Nasal Spray.

AD = abuse-deterrent; ER = extended release.
*Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

OXAYDO is a registered trademark of Egalet Corporation.
SPRIX is a registered trademark of Egalet Corporation.
ARYMO ER is a registered trademark of Egalet Corporation.
  • Technology Overview
  • Pipeline
    • Chronic Pain
    • Prescription Drug Abuse
  • Manufacturing
  • Resources

CAREERS

Find out more about opportunities with Egalet.

Career Contact
careers@egalet.com

QUICK LINKS

Sign up for Egalet email alerts.

Investor Contact
ir@egalet.com

Media Contact
media@egalet.com

EGALET

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

General Contact
info@egalet.com

© Copyright 2016 Egalet Corporation All rights reserved.   Disclaimer | Privacy Policy | Sitemap

Delivering pain relief with peace of mind

Scroll to top